Open-Label study of ASP9801, an Oncolytic Virus administered by intratumoral injection in patients with advanced/metastatic solid tumors (9801-CL-0101)
Open-Label study of ASP9801, an Oncolytic Virus administered by intratumoral injection in patients with advanced/metastatic solid tumors (9801-CL-0101)
Trial Category:
Other Solid Tumor
Phase
I
Contact(s)
Location(s)
Nebraska Cancer Specialists, Omaha, NE
